Check Your Fridge: Trader Joe's Is Recalling More Than 61,000 Bottles of Sparkling Water
On Wednesday March 13, Trader Joe's issued a recall for specific lot numbers of Gerolsteiner Sparkling Natural Mineral Water, which the company said "may have the potential for cracked or damaged bottles."
According to a report from the U.S. Consumer Product Safety Commission (CPSC), the recall applies to the 750 mL bottles of Gerolsteiner Sparkling Natural Mineral Water, and includes about 61,500 bottles.
The recall was initiated after the supplier of the German-manufactured water informed Trader Joe's that certain lot codes contain bottles that may be damaged or can crack. Only two lot codes are affected, numbers 2024/28/11 24 2027/19/12 and 2024/271/11 24 2027/18/12. Consumers can find these printed on the side of the label on a bottle, to verify whether they need to discard their purchase.
While it may seem silly to recall water bottles based on the potential for cracking, these bottles are made from glass, which presents a notable safety hazard if they should break open.
Trader Joe's reports that the bottles were sold between December 27, 2024, and January 28, 2025. They were available for sale in 12 states — Alabama, Arkansas, Colorado, Florida, Georgia, Kansas, Louisiana, New Mexico, Oklahoma, South Carolina, Tennessee, and Texas — and were sold for about $3 per bottle, per the CPSC.
"There have been no customer reports of injury or damaged bottles," Trader Joe's notes thus far. "The issue was identified by research related to bottle breakage during production and potentially affects 1% of bottles in the lot codes above."
Related: Experts Warn of Public Health Risks as the Trump Administration Eliminates 2 Critical Food Safety Committees
The grocery chain adds that if you have one or more of these bottles with an affected lot code printed on the side, to "please" not consume or keep it. Instead, you should dispose of it carefully or head to any Trader Joe's for a full refund.
The CPSC further clarifies that, "Consumers will not be asked for proof of purchase but will need to return the recalled bottle to receive a refund (in the form of cash or credit)." So if you want a refund, it's best to bring the water with you to TJ's — just use caution while en route — then maybe grab a snack while you're there.Product recalled: Gerolsteiner Sparkling Natural Mineral Water 750mLReason for recall: Glass bottles that may be damaged or potentially crackNumber of bottles: About 61,500 bottlesStates affected: Alabama, Arkansas, Colorado, Florida, Georgia, Kansas, Louisiana, New Mexico, Oklahoma, South Carolina, Tennessee, TexasLot codes: 2024/28/11 24 2027/19/12 and 2024/271/11 24 2027/18/12Read the original article on Food & Wine
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
2 hours ago
- Miami Herald
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Hamilton Spectator
6 hours ago
- Hamilton Spectator
More than 100 aid groups warn of starvation in Gaza as Israeli strikes kill 21, officials say
DEIR AL-BALAH, Gaza Strip (AP) — More than 100 charity and human rights groups said Wednesday that Israel's blockade and ongoing military offensive are pushing Palestinians in the Gaza Strip toward starvation, as Israeli strikes killed another 21 people overnight, according to local health officials. Meanwhile, the Trump administration's Mideast envoy, Steve Witkoff, was set to meet with a senior Israeli official about ceasefire talks, a sign that lower-level negotiations that have dragged on for weeks could be approaching a breakthrough. Experts say Gaza is at risk of famine because of Israel's blockade and offensive, launched in response to Hamas' Oct. 7, 2023, attack. The head of the World Health Organization said Gaza is 'witnessing a deadly surge' in malnutrition and related diseases, and that a 'large proportion' of its roughly 2 million people are starving. Israel says it allows enough aid into the territory and faults delivery efforts by U.N. agencies, which say they are hindered by Israeli restrictions and the breakdown of security. Hamas has said it will only release the remaining 50 hostages it holds, around 20 of them believed to be alive, in exchange for a lasting ceasefire and an Israeli withdrawal. Israel has vowed to recover all the captives and continue the war until Hamas has been defeated or disarmed. 'Chaos, starvation and death' In an open letter, 115 organizations, including major international aid groups such as Doctors Without Borders, Mercy Corps and Save the Children, said they were watching their own colleagues, as well as the Palestinians they serve, 'waste away.' The letter blamed Israeli restrictions and 'massacres' at aid distribution points. Witnesses, health officials and the U.N. human rights office say Israeli forces have repeatedly fired on crowds seeking aid, killing more than 1,000 people . Israel says its forces have only fired warning shots and that the death toll is exaggerated. The Israeli government's 'restrictions, delays, and fragmentation under its total siege have created chaos, starvation, and death,' the letter said. WHO Director Tedros Adhanom Ghebreyesus echoed that criticism, telling reporters that acute malnutrition centers in Gaza are full of patients and lack adequate supplies. He said rates of acute malnutrition exceed 10% and that among pregnant and breastfeeding women, more than 20% are malnourished, often severely. The U.N. health agency's representative in the occupied Palestinian territories, Dr. Rik Peeperkorn, said there were more than 30,000 children under 5 with acute malnutrition in Gaza and that the WHO had reports that at least 21 children under 5 have died so far this year. Israel says critics are 'echoing Hamas' propaganda' The Israeli Foreign Ministry rejected the criticism in the open letter and accused the groups of 'echoing Hamas' propaganda.' It said it has allowed around 4,500 aid trucks into Gaza since lifting a complete blockade in May, and that more than 700 are waiting to be picked up and distributed by the U.N. That's an average of around 70 trucks a day, the lowest rate of the war and far below the 500 to 600 trucks a day the U.N. says are needed, and which entered during a six-week ceasefire earlier this year. The U.N. says it has struggled to deliver aid inside Gaza because of Israeli military restrictions, ongoing fighting and a breakdown of law and order. An alternative system established by Israel and an American contractor has been marred by violence and controversy . Top adviser to Netanyahu will meet US envoy in Rome An official familiar with ceasefire negotiations between Israel and Hamas said Ron Dermer, a top adviser to Israeli Prime Minister Benjamin Netanyahu, was traveling to Rome to meet Witkoff on Thursday to discuss the state of the talks. The official spoke Wednesday on condition of anonymity because they were not authorized to discuss the sensitive negotiations. U.S. officials said Witkoff planned to head to Europe this week. The State Department spokesperson said he was headed to the Middle East in a sign that momentum may be building toward a deal. The evolving deal is expected to include a 60-day ceasefire in which Hamas would release 10 living hostages and the remains of 18 others in phases in exchange for Palestinians imprisoned by Israel. Aid supplies would be ramped up, and the two sides would hold negotiations on a lasting truce. Overnight strikes kill at least 21 Israel has continued to carry out waves of daily airstrikes against what it says are militant targets but which often kill women and children. Israel blames civilian deaths on Hamas because the militants operate in densely populated areas. Strikes overnight and into Wednesday killed at least 21 people, more than half of them women and children, according to local health officials. One of the strikes hit a house in Gaza City, killing at least 12 people, according to Shifa Hospital , which received the casualties. The dead included six children and two women, according to Gaza's Health Ministry. The Israeli military said it struck an Islamic Jihad militant, and that the incident was under review because of reports of civilian casualties. Another strike hit an apartment in northern Gaza, killing at least six people. Among the dead were three children and two women, including one who was pregnant. Eight others were wounded, the ministry said. A third strike hit a tent in Gaza City late Tuesday and killed three children, Shifa Hospital said. There was no immediate comment from the military on those strikes. Hamas-led militants abducted 251 people in the Oct. 7 attack and killed around 1,200 people, mostly civilians. More than 59,000 Palestinians have been killed during the war, according to Gaza's Health Ministry. Its count doesn't distinguish between militants and civilians, but the ministry says that more than half of the dead are women and children. The U.N. and other international organizations see it as the most reliable source of data on casualties. ___ Goldenberg reported from Tel Aviv, Israel. ___ Follow AP's war coverage at Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Politico
8 hours ago
- Politico
A health care lobbying boom
Presented by Driving the Day MONEY TALKS — U.S. health care companies are pouring unprecedented sums of money into lobbying efforts as they vie for influence with the Trump administration and the GOP congressional majority, POLITICO's Amanda Chu reports. Newly released lobbying disclosure reports show the Pharmaceutical Research and Manufacturers of America, the trade group for brand-name drugmakers, spent $7.58 million on lobbying in the second quarter, the highest amount it's spent for the period, according to a POLITICO analysis. Leading members Bristol-Myers Squibb and Merck recorded their highest spending for any quarter. Insurance companies have also boosted spending. AHIP, the industry group, spent $4.05 million in the second quarter, its highest for the period on record. The American Hospital Association, meanwhile, reported $6.15 million, its second-highest for the period. The record spending comes as the Trump administration vies to overhaul the U.S. health care sector, posing the biggest threat to industry profits in years and signaling a broader shift in the relationship between corporate America and the traditionally pro-business Republican Party. President Donald Trump has approved nearly a $1 trillion cut in federal funding for Medicaid, threatened to impose tariffs on pharmaceuticals and demanded that drugmakers lower their prices. Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of vaccines, rolling back Covid-19 guidance for healthy children and healthy pregnant women, and overhauling the CDC's advisory panel on vaccines. 'Historically, the business community has seen total Republican control of D.C. as a period of great opportunity for their legislative priorities,' said Jeffrey Kimbell, president of Kimbell & Associates, which represents large pharmaceutical companies. 'While that is still the case, the current administration and some Republicans in Congress also require some industries to continue their defensive posture.' Lobbying firms with ties to key lawmakers and administration officials are reaping the benefits as companies and trade groups seek inroads with Trump and Republicans in Congress. Tarplin, Downs & Young and Todd Strategy Group ranked among the top firms representing pharmaceutical companies in Washington in the second quarter, according to a POLITICO analysis of disclosures. Each firm has strong GOP connections. Linda Tarplin was HHS's liaison to Congress when George H.W. Bush was president. Dan Todd worked for then-Utah GOP Sen. Orrin Hatch on the Finance Committee. WELCOME TO WEDNESDAY PULSE. This is your friendly CMS reporter, Robert King, filling in for your regular hosts Sophie and Kelly today. I am still picking through thousands of pages of payment rules released last week. If you have any thoughts, or know something I missed, please share at rking@ or khooper@ and sgardner@ and follow along @rking_19, @kelhoops and @sophie_gardnerj. In Congress LAWMAKERS TEE OFF ON MA — After a bruising fight over Medicaid cuts in President Donald Trump's megabill, Republicans and Democrats joined together on a health issue they both agree on: reining in privately run Medicare Advantage plans. Members of the House Ways and Means Committee's oversight and health panels discussed during a hearing Tuesday the need for reforms to the popular program that enables older Americans to receive benefits like hearing and vision care outside of traditional Medicare. Lawmakers blasted the plans for high rates of care denials and overspending. 'We know of concerns about MA plans inflating a patient's level of sickness resulting in higher reimbursements for the plan at taxpayer expense,' said Chair Jason Smith (R-Mo.). 'An estimated $40 billion in 2025 alone.' Rep. Lloyd Doggett(D-Texas), ranking member of the panel's Health Subcommittee, said the plans have been overspending traditional Medicare despite the intention to do the opposite. 'Medicare Advantage was sold as a program to save taxpayer dollars and improve quality of care, but I have found that it is largely disadvantages,' he said. Why it matters: The hearing was a spark of bipartisan comity after months of acrimony surrounding the One Big Beautiful Bill Act, which Congress passed earlier this month. The legislation included more than $1 trillion in cuts to health spending over the next decade, with most cuts coming from Medicaid. Medicare Advantage reforms have long engendered bipartisan support — but not enough to get them through Congress. Lawmakers are making another run. Doggett and Rep. Greg Murphy (R-N.C.), chair of the GOP Doctors Caucus, introduced legislation Monday that would mandate MA contract rates to providers. Some MA plans and hospitals have clashed nationwide over rates, with hospitals complaining about high levels of prior authorization requests. The Prompt and Fair Pay Act would mandate MA plans to reimburse all covered items and services for at least what Medicare pays, noting that some plans pay providers below that line. AROUND THE AGENCIES THEORY LIVES ON — In a new report on Covid-19's origins, Dr. Robert Kadlec, who was a top health official in the first Trump administration, says Chinese military researchers might have played a role in developing the virus, POLITICO's Carmen Paun reports Kadlec, who led the Covid-19 vaccine development program known as Operation Warp Speed, would be well-positioned to push for greater scrutiny of China if the Senate confirms him as assistant secretary of defense for nuclear, chemical and biological defense programs. The White House and congressional Republicans have embraced the hypothesis that a lab leak, and not a natural spillover of the virus from animals to humans, triggered the pandemic that killed millions of people globally. Zooming in: The report, published Monday by the Scowcroft Institute of International Affairs at Texas A&M University's Bush School of Government and Public Service, adds to the assertion by three U.S. intelligence agencies that the pandemic started as an accidental lab leak in Wuhan, China, where the first Covid cases were reported in late 2019. The agencies haven't alleged a Chinese military role. But, but, but: There's still no scientific consensus on how the pandemic began, with many virologists continuing to argue that the virus wasn't engineered and the global outbreak had a natural origin. A spokesperson for the Chinese embassy in Washington pointed to a 2021 report by the Chinese government and World Health Organization-appointed experts that concluded that a lab leak origin was 'extremely unlikely.' The spokesperson called that conclusion 'the authoritative scientific conclusion drawn by the China-WHO joint expert group based on field visits to relevant laboratories in Wuhan and in-depth exchanges with relevant scientific researchers.' While Kadlec's report states that a natural spillover from animals to humans remains a possibility, he argues that's doubtful because the virus contains features from different coronavirus strains that don't exist in nature in close proximity. That makes it unlikely that the virus recombination would have happened naturally, he said. Kadlec's concerns about Covid's lingering effects on the brain conflict with Health Secretary Robert F. Kennedy Jr.'s push to deemphasize Covid vaccination. Given the potential for even mild Covid infections triggering long Covid in children and adults, Kadlec's report calls for efforts to screen and test children. The Trump administration suspended a program offering free tests in March. Public Safety ORGAN OVERSIGHT FAILURES — House lawmakers grilled leaders in the nation's organ procurement and donation system Tuesday after a federal report revealed that an organ procurement organization had operated on patients showing signs of life, POLITICO's Amanda Friedman reports. The House Energy and Commerce Oversight and Investigations Subcommittee's hearing followed a Health Resources and Services Administration investigation into the Kentucky-based OPO, Network for Hope. A report released in March found that the OPO had harvested organs from more than two dozen patients who might not have been definitively deceased, failed to reassess brain function and kept poor records of what happened. Subcommittee Chair John Joyce (R-Pa.) said the findings 'fractured the physician-patient relationship' and demanded accountability from the OPO and the United Network for Organ Sharing, the nonprofit that oversees the national transplant system. Dr. Raymond Lynch, who leads HRSA's Organ Transplant Branch, told lawmakers the issues aren't isolated: 'Unfortunately, it is not limited to [Network for Hope].' Other concerns: Members also raised concerns about systematic racism and whistleblower retaliation. UNOS CEO Maureen McBride faced questions about racial bias lawsuits, while Network for Hope CEO Barry Massa defended his group's procedures but acknowledged communication failures. What's next: HHS warned the OPO could be decertified on Monday. HRSA gave the group until July 28 to submit an initial remediation plan. Names in the News Vincent Bellomo is now an adviser at the Department of Health and Human Services. He most recently was a special assistant to the Secretary of HHS. WHAT WE'RE READING POLITICO's David Lim reports on the confirmation of Terry Cole to head the Drug Enforcement Administration. POLITICO's Katherine Tully-McManus reports that Sen. Elizabeth Warren (D-Mass.) will vote against the Senate's first batch of funding bills — signaling her party that she won't be cooperative in the fall funding fight. The New York Times's Nina Agrawal and Allison Jiang write about the changing face of lung cancer.
